These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26172395)
1. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial. Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395 [TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Yang C; Bosker FJ; Li J; Schoevers RA BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of administration of oral N-acetylcysteine to reduce oxidative stress in chronic hemodialysis patients: A double-blind, randomized, controlled clinical trial. Shahbazian H; Shayanpour S; Ghorbani A Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):88-93. PubMed ID: 26787572 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine supplementation increases exercise performance and reduces oxidative stress only in individuals with low levels of glutathione. Paschalis V; Theodorou AA; Margaritelis NV; Kyparos A; Nikolaidis MG Free Radic Biol Med; 2018 Feb; 115():288-297. PubMed ID: 29233792 [TBL] [Abstract][Full Text] [Related]
7. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study. Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464 [TBL] [Abstract][Full Text] [Related]
8. Effect of N-acetylcysteine administration on homocysteine level, oxidative damage to proteins, and levels of iron (Fe) and Fe-related proteins in lead-exposed workers. Kasperczyk S; Dobrakowski M; Kasperczyk A; Romuk E; Rykaczewska-Czerwińska M; Pawlas N; Birkner E Toxicol Ind Health; 2016 Sep; 32(9):1607-18. PubMed ID: 25731901 [TBL] [Abstract][Full Text] [Related]
9. The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial. Skvarc DR; Dean OM; Byrne LK; Gray LJ; Ives K; Lane SE; Lewis M; Osborne C; Page R; Stupart D; Turner A; Berk M; Marriott AJ Trials; 2016 Aug; 17():395. PubMed ID: 27502769 [TBL] [Abstract][Full Text] [Related]
10. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial]. Correa MJ; Mariz HA; Andrade LE; Kayser C Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027 [TBL] [Abstract][Full Text] [Related]
11. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Kumar P; Liu C; Hsu JW; Chacko S; Minard C; Jahoor F; Sekhar RV Clin Transl Med; 2021 Mar; 11(3):e372. PubMed ID: 33783984 [TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA Mol Autism; 2016; 7():26. PubMed ID: 27103982 [TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial. Zhang Q; Ju Y; Ma Y; Wang T Medicine (Baltimore); 2018 Nov; 97(45):e13087. PubMed ID: 30407312 [TBL] [Abstract][Full Text] [Related]
14. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer. Visacri MB; Quintanilha JCF; de Sousa VM; Amaral LS; de F L Ambrósio R; Calonga L; Curi SFBB; de T Leme MF; Chone CT; Altemani JMC; Mazzola PG; Malaguti C; Vercesi AE; Lima CSP; Moriel P Cancer Med; 2019 May; 8(5):2020-2030. PubMed ID: 30977273 [TBL] [Abstract][Full Text] [Related]
15. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. Khatami PG; Soleimani A; Sharifi N; Aghadavod E; Asemi Z J Clin Lipidol; 2016; 10(4):922-929. PubMed ID: 27578124 [TBL] [Abstract][Full Text] [Related]
16. Effect of N-acetylcysteine on cycling performance after intensified training. Slattery KM; Dascombe B; Wallace LK; Bentley DJ; Coutts AJ Med Sci Sports Exerc; 2014 Jun; 46(6):1114-23. PubMed ID: 24576857 [TBL] [Abstract][Full Text] [Related]
17. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis. Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541 [TBL] [Abstract][Full Text] [Related]
18. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial. Mahmoud KM; Ammar AS Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168 [TBL] [Abstract][Full Text] [Related]
19. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Nascimento MM; Suliman ME; Silva M; Chinaglia T; Marchioro J; Hayashi SY; Riella MC; Lindholm B; Anderstam B Perit Dial Int; 2010; 30(3):336-42. PubMed ID: 20190028 [TBL] [Abstract][Full Text] [Related]
20. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo. Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]